Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin (original) (raw)

Tissue disposition of azithromycin after intravenous and intramuscular administration to rabbits

Carlos Cárceles

The Veterinary Journal, 2007

View PDFchevron_right

Cellular Uptake and Efflux of Azithromycin, Erythromycin, Clarithromycin, Telithromycin, and Cethromycin

Zeljko Kelnerić

Antimicrobial Agents and Chemotherapy, 2005

View PDFchevron_right

Azithromycin: Mechanisms of action and their relevance for clinical applications

Vesna Haber

Pharmacology & Therapeutics, 2014

View PDFchevron_right

Azithromycin--review of key chemical, pharmacokinetic and microbiological features

H. Lode

Journal of Antimicrobial Chemotherapy, 1996

View PDFchevron_right

Azithromycin distinctively modulates classical activation of human monocytes in vitro

Denis Polancec

British Journal of Pharmacology, 2012

View PDFchevron_right

Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo

Niels Frimodt-møller

Antimicrobial agents and chemotherapy, 1998

View PDFchevron_right

Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts

Donatienne Tyteca

European Journal of Cell Biology, 2001

View PDFchevron_right

Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin

Giuseppe Pasqualetti, Mario Del Tacca

Journal of Antimicrobial Chemotherapy, 2008

View PDFchevron_right

Azithromycin alters macrophage phenotype

Don Hayes

Journal of Antimicrobial Chemotherapy, 2008

View PDFchevron_right

Quantitative determination of azithromycin in plasma, blood and isolated neutrophils by liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonyl-chloride and fluorescence detection

Erik Wilms

Journal of Chromatography B, 2005

View PDFchevron_right

Azithromycin, a Lysosomotropic Antibiotic, Has Distinct Effects on Fluid-Phase and Receptor-Mediated Endocytosis, but Does Not Impair Phagocytosis in J774 Macrophages

Donatienne Tyteca

Experimental Cell Research, 2002

View PDFchevron_right

Stimulation with cytokines enhances penetration of azithromycin into human macrophages

Luiz Bermudez

Antimicrobial Agents and Chemotherapy, 1991

View PDFchevron_right

Focus on azithromycin

Natalie Schellack

South African General Practitioner, 2021

View PDFchevron_right

Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses

Paul Gubbins

Antimicrobial agents and chemotherapy, 1996

View PDFchevron_right

Azithromycin – more than an antibiotic

Adam Sybilski

Pediatria i Medycyna Rodzinna

View PDFchevron_right

Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes

Eric Wolford

International journal of …, 2002

View PDFchevron_right

Validated HPLC–MS–MS method for determination of azithromycin in human plasma

Bojan Nemec

Analytical and Bioanalytical Chemistry, 2005

View PDFchevron_right

Azithromycin as Potent Inhibitor of Cell Migration in Tumor Cell Line

kauser moin

Journal of Hunan University Natural Sciences

View PDFchevron_right

Spectrophotometric analysis of Azithromycin and its pharmaceutical dosage forms: Comparison between Spectrophotometry and HPLC

Sitesh Bachar

Dhaka University Journal of Pharmaceutical Sciences, 2015

View PDFchevron_right

Safety, toleration, and pharmacokinetics of intravenous azithromycin

David Luke

Antimicrobial Agents and Chemotherapy

View PDFchevron_right

Disposition of oral azithromycin in humans

David Luke

Clinical pharmacology and therapeutics, 1997

View PDFchevron_right

Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity

Mariepaule Mingeotleclercq

European Journal of Pharmacology, 1996

View PDFchevron_right

Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg

Luigi Murri, Romano Danesi

Journal of Antimicrobial Chemotherapy, 2003

View PDFchevron_right

Comparative plasma exposure and lung distribution of two human use commercial azithromycin formulations assessed in murine model: a preclinical study

Monica Ceci

BioMed research international, 2013

View PDFchevron_right

A liquid chromatography-mass spectrometric method for the quantification of azithromycin in human plasma

Vishwa Somayaji

Biomedical Chromatography, 2013

View PDFchevron_right